Full Text (PDF)
Original Article

A Prospective Study on Effect of Low Dose Mifepristone in Uterine Leiomyoma

Gnanasabai Gnanamani , Geetha Krishnamoorthy1 , Gnanamani Gnanasabai2 , Gulrukh Hashmi3

Author Information

Licence:




Indian Journal of Obstetrics and Gynecology 7(2):p 303-308, April-June 2019. | DOI: DOI: http://dx.doi.org/10.21088/ijog.2321.1636.7219.30

How Cite This Article:

Geetha Krishnamoorthy, Gnanamani Gnanasabai, Gulrukh Hashmi. A Prospective Study on Effect of Low Dose Mifepristone in Uterine Leiomyoma. Indian J Obstet Gynecol. 2019;7(2):303-308.


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Context: Uterine leiomyomas is the most common benign tumor of the uterus and one of the most frequent indications for operative procedures. High dose of mifepristone used to treat leiomyomas have resulted in side effects. Hence this study was done to evaluate effects of low dose mifepristone. Aims: To evaluate the effectiveness of low dose Mifepristone in the treatment of Uterine Leiomyoma. Settings and Design: A prospective observational study was conducted among 60 women diagnosed with uterine leiomyoma in a tertiary hospital at Karaikal. Methods and Material: Data was collected using standardized questionnaire. Blood investigation and ultrasound pelvis was done to evaluate the effects on uterine leiomyoma before and after treatment with 10 mg of mifepristone for three months. Statistical analysis used: Mean and standard deviations were used to present quantitative data. Association was tested using Chi square, McNemar test, Paired t test and Wilcoxin test. Results: Maximum participants were between 40-49 years. More than half of the study participants were relieved of dysmenorrhea after the treatment. The Mean PBAC values reduced from 124.6 ± 51.85 to 34.72 ± 17.87 which was highly significant. There was significant reduction in the uterine volume from 331.69 ± 216.05 to 239.68 ± 157.23 cm3 and the Leiomyoma volume from 68.62 ± 38.94 to 46.71 ± 27.96 cm3. About 78% of the study population experienced amenorrhea after the therapy. Conclusions: Low dose of Mifepristone was effective in reducing the size of uterine leiomyoma and also decreasing symptoms of dysmenorrhoea and menorrhagia thus improving the general health status and quality of life of the study population.


References

No records found.


About this article


Cite this article

Geetha Krishnamoorthy, Gnanamani Gnanasabai, Gulrukh Hashmi. A Prospective Study on Effect of Low Dose Mifepristone in Uterine Leiomyoma. Indian J Obstet Gynecol. 2019;7(2):303-308.


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: http://dx.doi.org/10.21088/ijog.2321.1636.7219.30

Keywords

Amenorrhea; Dysmenorrhea; Leiomyomas; Mifepristone.

Article Level Metrics

Last Updated

Thursday 09 July 2026, 04:32:42 (IST)


1883

Accesses

3
349
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share